Last Posted: Jan 17, 2019
- Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer.
Sundar R et al. Annals of oncology : official journal of the European Society for Medical Oncology 2019 Jan
- Highly mutated cancers respond better to immune therapy-The complex tests that gauge mutation levels will pose a challenge in the clinic.
H Ledford, Nature, January 15, 2016
- Recent advances in Lynch syndrome.
Biller Leah H et al. Familial cancer 2019 Jan
- Clinical applications of CRISPR-based genome editing and diagnostics.
Foss Dana V et al. Transfusion 2019 Jan
- Immune Checkpoint Inhibitors
NCI Video, 2018
- Next-Generation Sequencing-Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer: Potential Implications for Clinical Management.
Gupta Sounak et al. The Journal of molecular diagnostics : JMD 2018 Dec
- Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine.
Valle Laura et al. The Journal of pathology 2018 Dec
- Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives.
Arbitrio Mariamena et al. High-throughput 2018 Dec 7(4)
- High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
SM Vareki, Genome Biology, December 27, 2018
- [Lynch syndrome: What is new?]
Pellat Anna et al. Bulletin du cancer 2018 Dec
- NIH Resources (12)
- CDC-Authored Publications (29)
- Epidemiologic Studies (453)
- Translation/Implementation Studies (39)
- Evidence Synthesis (1)
- Guidelines (3)
- Reviews/Commentaries (140)
- Ethical/Legal and Social Issues (1)
- AMD Weekly Clips (81)
- GWAS Catalog (2)
- Grants Supporting Publications
- Genetic Testing (GTR)
- Genetic Disease (OMIM)
- PubMed Review
- PubMed Clinical Queries
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Mar 1, 2018
- Page last updated:Jan 20, 2019
- Content source: